Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1130

1.

Direct modulation of myelin-autoreactive CD4+ and CD8+ T cells in EAE mice by a tolerogenic nanoparticle co-carrying myelin peptide-loaded major histocompatibility complexes, CD47 and multiple regulatory molecules.

Pei W, Wan X, Shahzad KA, Zhang L, Song S, Jin X, Wang L, Zhao C, Shen C.

Int J Nanomedicine. 2018 Jun 27;13:3731-3750. doi: 10.2147/IJN.S164500. eCollection 2018.

2.

Helicobacter pylori infection and demyelinating disease of the central nervous system.

Kira JI, Isobe N.

J Neuroimmunol. 2018 Jun 30. pii: S0165-5728(18)30181-4. doi: 10.1016/j.jneuroim.2018.06.017. [Epub ahead of print] Review.

PMID:
29983199
3.

Sodium chloride triggers Th17 mediated autoimmunity.

Haase S, Wilck N, Kleinewietfeld M, Müller DN, Linker RA.

J Neuroimmunol. 2018 Jun 30. pii: S0165-5728(17)30512-X. doi: 10.1016/j.jneuroim.2018.06.016. [Epub ahead of print] Review.

PMID:
29983198
4.

Dysregulated MicroRNA Involvement in Multiple Sclerosis by Induction of T Helper 17 Cell Differentiation.

Chen C, Zhou Y, Wang J, Yan Y, Peng L, Qiu W.

Front Immunol. 2018 Jun 4;9:1256. doi: 10.3389/fimmu.2018.01256. eCollection 2018. Review.

5.

IL-3 Is a Marker of Encephalitogenic T Cells, but Not Essential for CNS Autoimmunity.

Lee PW, Xin MK, Pei W, Yang Y, Lovett-Racke AE.

Front Immunol. 2018 Jun 4;9:1255. doi: 10.3389/fimmu.2018.01255. eCollection 2018.

6.

Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment.

Cunill V, Massot M, Clemente A, Calles C, Andreu V, Núñez V, López-Gómez A, Díaz RM, Jiménez MLR, Pons J, Vives-Bauzà C, Ferrer JM.

Front Immunol. 2018 May 29;9:1097. doi: 10.3389/fimmu.2018.01097. eCollection 2018.

7.

Tolerogenic β2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome.

Chao YH, Chen DY, Lan JL, Tang KT, Lin CC.

PLoS One. 2018 Jun 12;13(6):e0198821. doi: 10.1371/journal.pone.0198821. eCollection 2018.

8.

Down-regulation of RORA gene expression in the blood of multiple sclerosis patients.

Sayad A, Salmani T, Hemmesi MK, Ganji M, Ghafouri-Fard S, Hatami M, Soudyab M, Taheri M.

Hum Antibodies. 2018 May 25. doi: 10.3233/HAB-180341. [Epub ahead of print]

PMID:
29889063
9.

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.

Kaneko K, Sato DK, Nakashima I, Ogawa R, Akaishi T, Takai Y, Nishiyama S, Takahashi T, Misu T, Kuroda H, Tanaka S, Nomura K, Hashimoto Y, Callegaro D, Steinman L, Fujihara K, Aoki M.

J Neurol Neurosurg Psychiatry. 2018 Jun 6. pii: jnnp-2018-317969. doi: 10.1136/jnnp-2018-317969. [Epub ahead of print]

10.

Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.

Darlington PJ, Stopnicki B, Touil T, Doucet JS, Fawaz L, Roberts ME, Boivin MN, Arbour N, Freedman MS, Atkins HL, Bar-Or A.

Front Immunol. 2018 May 7;9:834. doi: 10.3389/fimmu.2018.00834. eCollection 2018.

11.

Gpr97/Adgrg3 ameliorates experimental autoimmune encephalomyelitis by regulating cytokine expression.

Wang J, Wang X, Chen X, Lu S, Kuang Y, Fei J, Wang Z.

Acta Biochim Biophys Sin (Shanghai). 2018 Jul 1;50(7):666-675. doi: 10.1093/abbs/gmy060.

PMID:
29860267
12.

Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis.

Dolati S, Ahmadi M, Rikhtegar R, Babaloo Z, Ayromlou H, Aghebati-Maleki L, Nouri M, Yousefi M.

Int Immunopharmacol. 2018 May 28;61:74-81. doi: 10.1016/j.intimp.2018.05.018. [Epub ahead of print]

PMID:
29852475
13.

PRMT1 Plays a Critical Role in Th17 Differentiation by Regulating Reciprocal Recruitment of STAT3 and STAT5.

Sen S, He Z, Ghosh S, Dery KJ, Yang L, Zhang J, Sun Z.

J Immunol. 2018 Jul 15;201(2):440-450. doi: 10.4049/jimmunol.1701654. Epub 2018 May 23.

PMID:
29794014
14.

Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis.

Dolati S, Marofi F, Babaloo Z, Aghebati-Maleki L, Roshangar L, Ahmadi M, Rikhtegar R, Yousefi M.

Biomed Pharmacother. 2018 Aug;104:280-290. doi: 10.1016/j.biopha.2018.05.050. Epub 2018 May 25. Review.

PMID:
29775896
15.

Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation.

Acharya S, Timilshina M, Jiang L, Neupane S, Choi DY, Park SW, Lee SY, Jeong BS, Kim JA, Nam TG, Chang JH.

Sci Rep. 2018 May 17;8(1):7799. doi: 10.1038/s41598-018-26088-y.

16.

Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice.

Holz K, Prinz M, Brendecke SM, Hölscher A, Deng F, Mitrücker HW, Rose-John S, Hölscher C.

Front Immunol. 2018 May 2;9:836. doi: 10.3389/fimmu.2018.00836. eCollection 2018.

17.

IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis.

Kurte M, Luz-Crawford P, Vega-Letter AM, Contreras RA, Tejedor G, Elizondo-Vega R, Martinez-Viola L, Fernández-O'Ryan C, Figueroa FE, Jorgensen C, Djouad F, Carrión F.

Front Immunol. 2018 Apr 30;9:802. doi: 10.3389/fimmu.2018.00802. eCollection 2018.

18.

Effect of Chronic Oxidative Stress on Neuroinflammatory Response Mediated by CD4+T Cells in Neurodegenerative Diseases.

Solleiro-Villavicencio H, Rivas-Arancibia S.

Front Cell Neurosci. 2018 Apr 27;12:114. doi: 10.3389/fncel.2018.00114. eCollection 2018. Review.

19.

PG201 protects mice from experimental autoimmune encephalomyelitis via suppression of effector T cell activation.

Bae MJ, Choi J, Kim HK, Lim S, Kim S.

Phytomedicine. 2018 Apr 1;43:150-157. doi: 10.1016/j.phymed.2018.04.026. Epub 2018 Apr 10.

PMID:
29747748
20.

Interleukin-27 Gene Therapy Prevents the Development of Autoimmune Encephalomyelitis but Fails to Attenuate Established Inflammation due to the Expansion of CD11b+Gr-1+ Myeloid Cells.

Zhu J, Liu JQ, Liu Z, Wu L, Shi M, Zhang J, Davis JP, Bai XF.

Front Immunol. 2018 Apr 24;9:873. doi: 10.3389/fimmu.2018.00873. eCollection 2018.

Supplemental Content

Loading ...
Support Center